113 related articles for article (PubMed ID: 28840980)
1. Is definitive concurrent chemoradiotherapy effective for locally advanced head and neck cancer in the elderly aged ≥ 75 years: A single-institute, retrospective, cohort study.
Lai KM; Lin JT; Lu HJ; Liang CC; Chen MK
Asia Pac J Clin Oncol; 2018 Jun; 14(3):247-255. PubMed ID: 28840980
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
4. Survival Rates of Concurrent Chemo-Radiation versus Radiation Alone in Locally Advanced, Unresectable Head and Neck Cancers: A Retrospective Cohort Study.
Eursritanakorn S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S91-8. PubMed ID: 27266222
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan.
Yasuda K; Uchinami Y; Kano S; Taguchi J; Kawakita D; Kitayama M; Nishioka K; Mori T; Koizumi F; Fujii Y; Shimizu Y; Kobashi K; Yoshimoto S; Nibu KI; Homma A; Aoyama H
Int J Clin Oncol; 2024 Mar; 29(3):241-247. PubMed ID: 38155239
[TBL] [Abstract][Full Text] [Related]
6. Current management of locally advanced head and neck cancer: the combination of chemotherapy with locoregional treatments.
Bar-Ad V; Palmer J; Yang H; Cognetti D; Curry J; Luginbuhl A; Tuluc M; Campling B; Axelrod R
Semin Oncol; 2014 Dec; 41(6):798-806. PubMed ID: 25499638
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.
Shirasu H; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Mori K; Yasui H
BMC Cancer; 2020 Mar; 20(1):182. PubMed ID: 32131771
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Haddad R; O'Neill A; Rabinowits G; Tishler R; Khuri F; Adkins D; Clark J; Sarlis N; Lorch J; Beitler JJ; Limaye S; Riley S; Posner M
Lancet Oncol; 2013 Mar; 14(3):257-64. PubMed ID: 23414589
[TBL] [Abstract][Full Text] [Related]
9. Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).
Ghadjar P; Pöttgen C; Joos D; Hayoz S; Baumann M; Bodis S; Budach W; Studer G; Stromberger C; Zimmermann F; Kaul D; Plasswilm L; Olze H; Bernier J; Wust P; Aebersold DM; Budach V
Strahlenther Onkol; 2016 Aug; 192(8):552-60. PubMed ID: 27323753
[TBL] [Abstract][Full Text] [Related]
10. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
[TBL] [Abstract][Full Text] [Related]
13. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
[TBL] [Abstract][Full Text] [Related]
17. Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy.
Nenclares P; Bhide SA; Sandoval-Insausti H; Pialat P; Gunn L; Melcher A; Newbold K; Nutting CM; Harrington KJ
Eur J Cancer; 2020 May; 131():9-15. PubMed ID: 32248073
[TBL] [Abstract][Full Text] [Related]
18. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
[TBL] [Abstract][Full Text] [Related]
19. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
Ock CY; Keam B; Lim Y; Kim TM; Lee SH; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
Head Neck; 2016 Feb; 38(2):277-84. PubMed ID: 26104823
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]